alexa Rationale for Bone Marrow Transplantation in Treatment of Various Intractable Diseases | OMICS International
ISSN: 1745-7580
Immunome Research
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Rationale for Bone Marrow Transplantation in Treatment of Various Intractable Diseases

Susumu Ikehara*

Department of Stem Cell Disorders, Kansai Medical University, Hirakata City, Osaka, Japan

*Corresponding Author:
Susumu Ikehara, M.D., Ph.D
Department of Stem Cell Disorders
Kansai Medical University, Hirakata City
Osaka 570-1010, Japan
Tel: 81-72-804-2450
Fax: 81-72-804-2454
E-mail: [email protected]

Received date: February 06, 2015 Accepted date: May 22, 2015 Published date: May 25, 2015

Citation: Ikehara S (2015) Rationale for Bone Marrow Transplantation in Treatment of Various Intractable Diseases. Immunome Res 11:091. doi:10.4172/1745-7580.1000091

Copyright: © 2015 Ikehara S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Immunome Research


In this article, we provide evidence that bone marrow transplantation (BMT) can be used to treat various
otherwise intractable diseases. We also show which currently incurable diseases could be treated using our novel BMT methods.


Autoimmune diseases; Type 1 Diabetes mellitus; Bone marrow; Bone marrow cells; Bone marrow transplantation; Stem cell disorder; Hemopoietic stem cell; Mesenchymal stem cell; Primitive stem cell; Aspiration method; Perfusion method; Intra-bone marrow


As long ago as 1985, we discovered, using animal models for autoimmune diseases, that conventional allogeneic BMT could be used to prevent and also treat not only systemic but also organ-specific autoimmune diseases (AIDs).

Our research at that time showed that conventional allogeneic BMT could be used to prevent not only TIDM in NOD mice [1] but also lupus nephritis in lupus mice [2]. In contrast, when BMT was carried out from autoimmune-prone mice to normal mice, the chimeras showed AIDs, strongly suggesting that AIDs were derived from BM defects, since thymus grafts from autoimmune-prone mice to athymic (nu/nu) mice did not result in the development of AIDs [3]. Based on these findings, we focused our research on the BM and eventually discovered a number of BM defects [4-7].

We developed a BMT technique that combines a “PM” for collecting BMCs with the intra-bone marrow (IBM) injection of BMCs (IBM-BMT) [8] (Figure1). As distinct from the conventional AM, the PM allows rapid (within 1 h) collection of BMCs without T cell contamination (T cells<10%). Therefore, no GvHD occurs. Moreover, the burden on donors, such as back pain, bleeding and infection, can be reduced.


Figure 1: A new BMT method for allogeneic BMT. The new method consists of PM+IBM-BMT.

Full chimerism can be achieved even with only mild conditioning regimens if IBM-BMT is carried out, since IBM-BMT replaces not only the recipient’s HSCs but also MSCs with donor-derived HSCs and MSCs. The findings to date strongly suggest that all the body’s cells originate in the BM, and that all diseases might therefore originate from defects in the BM. Indeed, one paper already suggests that gastric cancer originates from BM-derived cells [9].

Finally, I would like to propose a new concept of SCDs (Figure 2). On the one hand, there are HSC disorders, which include (i) aplasia of HSCs (aplastic anemia), (ii) monoclonal or oligoclonal abnormal HSC proliferative syndromes (leukemias and myelodysplastic syndrome), and (iii) polyclonal abnormal HSC proliferative syndromes (autoimmune diseases) [10,11].


Figure 2: A novel concept of stem cell disorders.

On the other hand, there are MSC disorders, which include age associated diseases such as osteoporosis [12] and emphysema [13], Alzheimer’s disease, and atherosclerosis [8,14]; it has been proposed that autoimmune mechanisms are involved in the development of atherosclerosis [15,16] and also Alzheimer’s disease [17].


We firmly believe that the development of our BMT method heralds a revolution not only in the field of transplantation (BMT and organ transplantation) but also in the fields of cancer and regeneration.


We would like to thank Mr. Hilary Eastwick-Field and Ms. Keiko Ando for their help in the preparation of the manuscript. These studies were mainly supported by the 21st Century Center of Excellence (COE) program of the Ministry of Education, Culture, Sports, Science and Technology. The Research on Allergic Disease and Immunology Committee from Health and Labour Sciences Research Grants of the Ministry of Health, Labour and Welfare. This study was supported by Otsuka Pharmaceutical Company, Ltd.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Article Usage

  • Total views: 12264
  • [From(publication date):
    August-2015 - May 24, 2018]
  • Breakdown by view type
  • HTML page views : 8463
  • PDF downloads : 3801

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

engi[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
Leave Your Message 24x7